News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Rejects Delcath Systems, Inc. (DCTH)'s Cancer Therapy, Fires CEO


9/13/2013 7:51:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Delcath Systems Inc said the U.S. Food and Drug Administration rejected its cancer therapy, and asked for more trials, more than four months after a panel of U.S. advisers recommended against its approval. The company also said it fired Chief Executive Eamonn Hobbs on September 10 and appointed two interim co-CEOs. Further studies should show that the treatment is safe and effective based on overall survival, and that benefits outweigh risks, the FDA said.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES